{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:01:17Z","timestamp":1773943277052,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.anndiagpath.2024.152292","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:22:04Z","timestamp":1709814124000},"page":"152292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies"],"prefix":"10.1016","volume":"70","author":[{"given":"Ver\u00f4nica","family":"Aparecida Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crislaine","family":"Aparecida da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rodrigues do Carmo Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Penna","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luisa","family":"Monteiro dos Santos Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Ant\u00f4nia dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Reis","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1801","key":"10.1016\/j.anndiagpath.2024.152292_bb0005","first-page":"11","article-title":"Diagnosis and management of nephrotic syndrome","volume":"261","author":"McCloskey","year":"2017","journal-title":"Practitioner"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152292_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5414\/CN107220","article-title":"Therapeutic regulation of complement in patients with renal disease - where is the promise?","volume":"77","author":"Thurman","year":"2012","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152292_bb0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000501827","article-title":"Co-deposition of IgM and C3 may indicate unfavorable renal outcomes in adult patients with primary focal segmental glomerulosclerosis","volume":"44","author":"Mirioglu","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152292_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136558","article-title":"Complement activation in patients with focal segmental glomerulosclerosis","volume":"10","author":"Thurman","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152292_bb0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/ki.2015.120","article-title":"IgM exacerbates glomerular disease progression in complement-induced glomerulopathy","volume":"88","author":"Panzer","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152292_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2012020187","article-title":"IgM contributes to glomerular injury in FSGS","volume":"24","author":"Strassheim","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152292_bb0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1053\/j.ajkd.2019.12.019","article-title":"Approach to diagnosis and Management of Primary Glomerular Diseases due to Podocytopathies in adults: Core curriculum 2020","volume":"75","author":"Ahn","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.anndiagpath.2024.152292_bb0040","doi-asserted-by":"crossref","unstructured":"Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502\u201317. doi:https:\/\/doi.org\/10.2215\/CJN.05960616. Epub 2017 Feb 27. Erratum in: Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1889.","DOI":"10.2215\/CJN.05960616"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152292_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajt.12045","article-title":"Recent progress in the pathophysiology and treatment of FSGS recurrence","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152292_bb0050","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"2015","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152292_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.kint.2023.05.018","article-title":"Repurposing drugs for diseases associated with podocyte dysfunction","volume":"104","author":"Shankland","year":"2023","journal-title":"Kidney Int"},{"issue":"18 Suppl 6","key":"10.1016\/j.anndiagpath.2024.152292_bb0060","doi-asserted-by":"crossref","first-page":"vi45","DOI":"10.1093\/ndt\/gfg1058","article-title":"Focal segmental glomerulosclerosis in adults","author":"Cameron","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1016\/j.anndiagpath.2024.152292_bb0065","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152292_bb0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-0034-1375299","article-title":"Treatment of C3 glomerulopathy with complement blockers","volume":"40","author":"Vivarelli","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152292_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234934","article-title":"Complement activation profile of patients with primary focal segmental glomerulosclerosis","volume":"15","author":"Huang","year":"2020","journal-title":"PloS One"},{"issue":"Supplement_2","key":"10.1016\/j.anndiagpath.2024.152292_bb0080","doi-asserted-by":"crossref","first-page":"ii29","DOI":"10.1093\/ndt\/gfad079","article-title":"Complement inhibitors for kidney disease","volume":"38","author":"Wooden","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152292_bb0090","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00467-009-1130-0","article-title":"Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome","volume":"24","author":"Swartz","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152292_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1442-200x.2001.01396.x","article-title":"Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children","volume":"43","author":"Zeis","year":"2001","journal-title":"Pediatr Int"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152292_bb0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/ndt\/15.7.981","article-title":"Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellularity","volume":"15","author":"Alexopoulos","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152292_bb0105","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1134\/S0006297911050038","article-title":"IgM and its receptors: structural and functional aspects","volume":"76","author":"Klimovich","year":"2011","journal-title":"Biochemistry (Mosc)"},{"issue":"10","key":"10.1016\/j.anndiagpath.2024.152292_bb0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.imbio.2006.06.011","article-title":"Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo","volume":"211","author":"McMullen","year":"2006","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152292_bb0115","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1038\/srep07824","article-title":"A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells in vitro","author":"Lei","year":"2015","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152292_bb0120","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1074\/jbc.M111.301044","article-title":"Studies of the pattern recognition molecule H-ficolin: specificity and purification","volume":"287","author":"Zacho","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152292_bb0125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s10157-018-01688-0","article-title":"Mesangial C4d deposition is independently associated with poor renal survival in patients with primary focal segmental glomerulosclerosis","volume":"23","author":"Heybeli","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152292_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3325\/cmj.2017.58.281","article-title":"IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis","volume":"58","author":"Pa\u010di\u0107","year":"2017","journal-title":"Croat Med J"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152292_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00853431","article-title":"Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular \u201cimmune deposits\u201d","volume":"2","author":"Habib","year":"1988","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152292_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13567-015-0171-6","article-title":"The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is involved in complement evasion","volume":"46","author":"Seele","year":"2015","journal-title":"Vet Res"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152292_bb0145","doi-asserted-by":"crossref","first-page":"28445","DOI":"10.1038\/srep28445","article-title":"A previously unrecognized role of C3a in proteinuric progressive nephropathy","author":"Morigi","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152292_bb0150","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.4049\/jimmunol.177.6.4094","article-title":"Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice","volume":"177","author":"Turnberg","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152292_bb0155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2215\/CJN.01190216","article-title":"Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis","volume":"11","author":"Zhang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152292_bb0160","article-title":"IgM and C3 deposition in primary focal segmental glomerulosclerosis (FSGS): a clinical and histopathological Spectrum","volume":"15","author":"Amer","year":"2023","journal-title":"Cureus"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:36:19Z","timestamp":1761078979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"alternative-id":["S1092913424000297"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152292","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152292"}}